Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,973
archived clinical trials in
High Cholesterol

Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Gurnee, IL
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gurnee, IL
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kansas City, KA
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Paducah, KY
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Paducah, KY
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Auburn, ME
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Olive Branch, MS
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Butte, MT
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Berlin, NJ
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Endwell, NY
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Willoughby Hills, OH
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Willoughby Hills, OH
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Simpsonville, SC
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Corpus Christi, TX
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kenosha, WI
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kenosha, WI
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Downingtown, PA
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Downingtown, PA
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Idaho State University
mi
from
Pocatello, ID
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Idaho State University
mi
from
Pocatello, ID
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Midwestern University
mi
from
Downers Grove, IL
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Midwestern University
mi
from
Downers Grove, IL
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Genesis Health System
mi
from
Davenport, IA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Genesis Health System
mi
from
Davenport, IA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Siouxland Medical Education Foundation
mi
from
Sioux City, IA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Siouxland Medical Education Foundation
mi
from
Sioux City, IA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Northeast Iowa Medical Education Foundation
mi
from
Waterloo, IA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Northeast Iowa Medical Education Foundation
mi
from
Waterloo, IA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
SUNY-University of Buffalo
mi
from
Buffalo, NY
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
SUNY-University of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Temple University
mi
from
Philadelphia, PA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Science Center
mi
from
Amarillo, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Science Center
mi
from
Amarillo, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Memorial Hermann Hospital System
mi
from
Houston, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Milwaukee Health Services, INC
mi
from
Milwaukee, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Milwaukee Health Services, INC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Advanced Cardiovascular, LLC, Research
mi
from
Auburn, AL
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Advanced Cardiovascular, LLC, Research
mi
from
Auburn, AL
Click here to add this to my saved trials